FDA Inspection
Ferndale Laboratories, Inc.Ferndale Laboratories, Inc. – FDA Inspection, Mar 4, 2022
Record Details
This FDA Inspection record concerns Ferndale Laboratories, Inc., with an inspection on March 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Ferndale Laboratories, Inc.
- Inspection Date
- March 4, 2022
- Product Type
- Drugs
View Company Profile
ID · abeecd32-0499-425c-b4e8-ec97d18c48b9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1163686
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.22(a)Authority lacking to review records, investigate errors
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ferndale Laboratories, Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| May 20, 2026 | Not classified | Detroit District Office | |
| February 27, 2026 | Not classified | Detroit District Office | |
| August 2, 2017 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| February 3, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 24, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ferndale Laboratories, Inc.
- FDA Inspection 1317968 - 2026-05-20
- FDA Inspection 1300752 - 2026-02-27
- FDA Inspection 1024384 - 2017-08-02
- FDA Inspection 1005288 - 2017-02-03
- FDA Inspection 924621 - 2015-04-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.